Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment‐naïve CLL patients.

MLA

Navrkalova, Veronika, et al. “Integrative NGS Testing Reveals Clonal Dynamics of Adverse Genomic Defects Contributing to a Natural Progression in Treatment‐naïve CLL Patients.” British Journal of Haematology, vol. 204, no. 1, Jan. 2024, pp. 240–49. EBSCOhost, https://doi.org/10.1111/bjh.19191.

APA

Navrkalova, V., Plevova, K., Radova, L., Porc, J., Pal, K., Malcikova, J., Pavlova, S., Doubek, M., Panovska, A., Kotaskova, J., & Pospisilova, S. (2024). Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment‐naïve CLL patients. British Journal of Haematology, 204(1), 240–249. https://doi.org/10.1111/bjh.19191

Chicago

Navrkalova, Veronika, Karla Plevova, Lenka Radova, Jakub Porc, Karol Pal, Jitka Malcikova, Sarka Pavlova, et al. 2024. “Integrative NGS Testing Reveals Clonal Dynamics of Adverse Genomic Defects Contributing to a Natural Progression in Treatment‐naïve CLL Patients.” British Journal of Haematology 204 (1): 240–49. doi:10.1111/bjh.19191.